Award

Delivery Order #SPE2DP26F2956

Delivery Order for Loperamide Hydrochloride under DMS Pharmaceutical Contract

Buyer

Defense Logistics Agency

Award Amount

$190.96

Ceiling

$190.96

Awarded

February 22, 2026

Period of Performance

Feb 22, 2026 – Feb 23, 2026

Identifier

SPE2DP26F2956

NAICS

424210

This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceuticals, focused on supplying the drug Loperamide Hydrochloride. It functions as a supplemental order under the existing definitive pharmaceutical supply contract awarded to DMS, reinforcing the agency's ongoing procurement of essential medications. The delivery order covers the provision of a specific pharmaceutical product used to manage diarrhea, ensuring timely availability to support healthcare treatments. This action contributes to the agency's strategic healthcare mission by maintaining a consistent supply chain for critical drugs. The order was placed within the framework of a competitive, long-term indefinite delivery vehicle contract, suggesting adherence to established procurement protocols. The period of performance is brief, spanning a couple of days, indicating a prompt fulfillment requirement. This delivery order supports the broader pharmaceutical supply contract active since 2025, demonstrating continued collaboration between the government and DMS Pharmaceutical Group to meet public health needs.

Description

8511936142!LOPERAMIDE HYDROCHL

View original record